Literature DB >> 10160093

Economic evaluation of an educational campaign for early diagnosis of cutaneous melanoma.

L Garattini1, T Cainelli, G Tribbia, D Scopelliti.   

Abstract

Public educational campaigns for the early diagnosis of cutaneous melanoma are considered an effective approach in the prevention of this disease, since they increase the number of cases detected early and consequently lengthen patients' life expectancy. We performed an economic evaluation of such a campaign in Bergamo, Italy, in order to quantify its costs and consequences. We used cost-effectiveness analysis to compare the costs and effects of the campaign with those of the 'do nothing' option. The analysis was performed from the perspective of the Italian National Health Service [the Servizio Sanitario Nazionale (SSN)]. Accordingly, only direct costs related to publicly financed healthcare services were considered. No indirect costs or benefits were considered because they are not relevant to the SSN. Incremental analysis was used to obtain results in terms of additional costs per life-year saved (LYS). Overall LYS were quantified by comparing the survival curves for 4 subgroups of patients with different lesional thicknesses at diagnosis ( < 0.76mm, 0.76 to 1.50mm, 1.51 to 3.00mm and > 3.00mm). All costs were estimated in 1993 Italian lire (L). Overall effectiveness amounted to 233.49 LYS. Using a 5% discount rate, the value of effectiveness was 171.3 LYS. The total cost of the educational campaign (i.e. the sum of the organisational and 'induced' costs minus the costs saved) was estimated at L817 million (approximate 1993 exchange rate $US1 = L1573), and L905 million after discounting at a rate of 5%. Thus, using discounted cost and effectiveness data, the cost of the educational campaign was L5.28 million per LYS.

Entities:  

Mesh:

Year:  1996        PMID: 10160093     DOI: 10.2165/00019053-199609020-00006

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  13 in total

1.  A proposal for Italian guidelines in pharmacoeconomics The Mario Negri Institute Centre for Health Economics.

Authors:  L Garattini; R Grilli; D Scopelliti; L Mantovani
Journal:  Pharmacoeconomics       Date:  1995-01       Impact factor: 4.981

2.  Skin cancer in Australia.

Authors:  W H McCarthy; H M Shaw
Journal:  Med J Aust       Date:  1989-05-01       Impact factor: 7.738

3.  The rate of malignant melanoma in the United States: are we making an impact?

Authors:  D S Rigel; A W Kopf; R J Friedman
Journal:  J Am Acad Dermatol       Date:  1987-12       Impact factor: 11.527

4.  [Cutaneous melanoma at the Turin Melanoma Center. I. Survival and correlation with clinical and histologic prognostic factors in 502 patients in stage I (1975-1985)].

Authors:  M G Bernengo; G C Doveil; F Lisa; M Pippione; F G Aloi; C Stuardi; G Zina
Journal:  G Ital Dermatol Venereol       Date:  1986 Sep-Oct       Impact factor: 2.011

Review 5.  Current therapy for cutaneous melanoma.

Authors:  T M Johnson; J W Smith; B R Nelson; A Chang
Journal:  J Am Acad Dermatol       Date:  1995-05       Impact factor: 11.527

6.  Risk for cutaneous melanoma in recent Connecticut birth cohorts.

Authors:  G C Roush; M J Schymura; T R Holford
Journal:  Am J Public Health       Date:  1985-06       Impact factor: 9.308

7.  Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma.

Authors:  U Veronesi; N Cascinelli
Journal:  Arch Surg       Date:  1991-04

8.  Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group.

Authors:  R MacKie; J A Hunter; T C Aitchison; D Hole; K Mclaren; R Rankin; K Blessing; A T Evans; A W Hutcheon; D H Jones
Journal:  Lancet       Date:  1992-04-18       Impact factor: 79.321

9.  Prognosis of stage I melanoma of the skin. Who collaborating centres for evaluation of methods of diagnosis and treatment of melanoma.

Authors: 
Journal:  Int J Cancer       Date:  1980-12-15       Impact factor: 7.396

10.  Melanoma case survival rates in South Australia by histological type, thickness and level of tumour at diagnosis.

Authors:  A Bonett; D Roder; A Esterman
Journal:  Med J Aust       Date:  1986-06-23       Impact factor: 7.738

View more
  1 in total

1.  Modelling the healthcare costs of skin cancer in South Africa.

Authors:  Louisa G Gordon; Thomas M Elliott; Caradee Y Wright; Nicola Deghaye; Willie Visser
Journal:  BMC Health Serv Res       Date:  2016-04-02       Impact factor: 2.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.